CRP and coronary artery disorder: The current study aimed to investigate the genetic basis of chemerin levels by conducting a GWAS in a Taiwan Biobank (TWB) population [17] and to confirm the crucial role of circulating chemerin levels and RARRES2 polymorphisms in the long-term outcome of patients with angiographically confirmed coronary artery disease (CAD), especially when combined with C-reactive protein (CRP) level.